Mn Services Vermogensbeheer B.V. increased its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 132.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 516,648 shares of the company's stock after purchasing an additional 294,560 shares during the quarter. Mn Services Vermogensbeheer B.V. owned approximately 0.06% of Colgate-Palmolive worth $44,080,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. TD Capital Management LLC raised its position in shares of Colgate-Palmolive by 61.4% in the fourth quarter. TD Capital Management LLC now owns 326 shares of the company's stock valued at $26,000 after buying an additional 124 shares during the last quarter. Parvin Asset Management LLC acquired a new stake in Colgate-Palmolive during the second quarter worth approximately $32,000. Park Place Capital Corp grew its stake in Colgate-Palmolive by 55.5% in the 2nd quarter. Park Place Capital Corp now owns 356 shares of the company's stock worth $33,000 after acquiring an additional 127 shares during the period. Cherry Tree Wealth Management LLC raised its holdings in Colgate-Palmolive by 7,840.0% in the 2nd quarter. Cherry Tree Wealth Management LLC now owns 397 shares of the company's stock valued at $36,000 after acquiring an additional 392 shares during the last quarter. Finally, Montgomery Financial Services LLC purchased a new position in shares of Colgate-Palmolive during the 2nd quarter worth $36,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Colgate-Palmolive
In related news, COO Panagiotis Tsourapas sold 10,000 shares of Colgate-Palmolive stock in a transaction on Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the transaction, the chief operating officer directly owned 64,901 shares in the company, valued at $5,974,137.05. The trade was a 13.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the transaction, the director directly owned 28,373 shares in the company, valued at $2,649,187.01. This represents a 12.81% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 175,191 shares of company stock worth $16,110,903. 0.43% of the stock is currently owned by insiders.
Colgate-Palmolive Stock Up 1.0%
NYSE CL opened at $88.07 on Friday. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The business has a 50 day moving average price of $89.16 and a two-hundred day moving average price of $88.77. The stock has a market cap of $70.21 billion, a PE ratio of 34.95, a P/E/G ratio of 4.07 and a beta of 0.33.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. During the same quarter last year, the firm posted $0.92 earnings per share. The business's quarterly revenue was up 4.9% on a year-over-year basis. As a group, sell-side analysts predict that Colgate-Palmolive Company will post 3.87 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be given a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 84.13%.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on CL. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Monday, August 3rd. JPMorgan Chase & Co. reduced their price objective on Colgate-Palmolive from $104.00 to $103.00 and set an "overweight" rating on the stock in a research note on Monday, August 3rd. Citigroup boosted their target price on Colgate-Palmolive from $105.00 to $110.00 and gave the stock a "buy" rating in a report on Tuesday, July 14th. Barclays increased their target price on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 21st. Finally, TD Cowen lifted their price target on shares of Colgate-Palmolive from $85.00 to $90.00 and gave the company a "hold" rating in a research report on Monday, August 3rd. Twelve research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $98.65.
Check Out Our Latest Report on Colgate-Palmolive
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.
The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom's of Maine and Hill's Science Diet.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.